Artemis Therapeutics Overview

  • Founded
  • 1997

  • Status
  • Public

  • Employees
  • 1

  • Stock Symbol
  • ATMS

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $0.30

  • (As of Thursday Closing)

Artemis Therapeutics General Information


Artemis Therapeutics Inc is exploring strategic alternatives. It is seeking a business combination candidate that would bring revenue and/or asset value to the company.

Contact Information

Formerly Known As
Artemis Pharma
Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • 18 East 16th Street
  • Suite 307
  • New York, NY 10003
  • United States
+1 (212) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Artemis Therapeutics Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.30 $0.70 $0.27 - $5.00 $78.4M 112M 3.04K -$0.04

Artemis Therapeutics Financials Summary

In Thousands,
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 135,590 5,054 2,153 364
Revenue 195 0 0 0
EBITDA (888) (154) (167) (168)
Net Income (869) (167) (121) (121)
Total Assets 356 7 11 22
Total Debt 356 196 110 103
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Artemis Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Artemis Therapeutics‘s full profile, request access.

Request a free trial

Artemis Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Tomer Assis Chief Financial Officer
Israel Alfassi Director
Kacey Mor-Vu Co-Founder
Nathalie Babazadeh Co-Founder
Dana Wolf Ph.D Chief Medical Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Artemis Therapeutics Board Members (1)

Name Representing Role Since
0000 00000 Self Board Member 000 0000
To view Artemis Therapeutics’s complete board members history, request access »

Artemis Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Artemis Therapeutics Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 (00000 30-Jun-2022 0000000000 000.00 Personal Products 00000 000
Inksure Technologies 23-Aug-2016 Merger/Acquisition IT Consulting and Outsourcing 000000 00
To view Artemis Therapeutics’s complete acquisitions history, request access »